바로가기
메인메뉴로 바로가기
콘텐츠 바로가기
하단메뉴로 바로가기
패밀리사이트 바로가기


동영상

안녕하세요. 저는 세브란스병원 소화기내과 안상훈입니다. 저의 진료분야는요. 간 질환입니다. 주로 만성간질환인 간염, 간경변증, 간암 환자에 대한 치료를 주로 하고 있습니다. 저의 전문분야는 바이러스성 간염 치료입니다. 따라서 치료가 굉장히 어려운 환자들에 있어서 바이러스 간염 치료를 통해서 바이러스를 완치시켜서 그 이후에 간 경변이나 간암으로 진행하는 것을 막는 데 있습니다. 간경변 환자들에 있어서는 여러 가지 합병증이 생기는 것에 따라서 적절한 치료를 하게 됩니다. 예를 들어 복수라든지 간성혼수, 그다음에 위 정맥류 출혈 같은 것들이 아주 주요한 간경변증의 합병증입니다. 또 간암은 그 병기에 따라서 수술적 치료부터 방사선 치료, 그다음에 색전술 등 다양한 치료를 하고 있습니다. 저의 진료철학은요. 저희가 환자들을 좀 가족처럼 대하고 사랑스럽게 생각하려고 노력하는 것이 저의 철학입니다. 그래서 어르신들이 오면 저희 부모같이 또 조금 더 젊은 친구들이 오면 저희 동생같이 저희가 치료를 하면서 좀 편안하게 환자가 진료실에 왔을 때 좀 편안하게 진료를 받고 좀 더 위안을 받고 가게 하려고 저는 진료실에서 농담도 많이 하고요. 제가 간 질환을 위해서 신약도 개발하고요. 그런 것들이 환자들에게 도움이 될 수 있는 그런 연구들을 많이 하는 것이 저의 미션입니다.

진료과

  • 연세암병원-간암센터

전문진료분야

  • <소화기내과> 간염(바이러스), 간암, 임상시험 특수센터

진료시간표

인터넷진료예약
의사시간표
진료시간
오전 본관 본관
오후 본관

교육 및 임상 경력

  • 연세의대  내과학교실  교수,  의학박사
  • 세브란스병원  기획관리실장  (2016-현재)
  • 해외연수]
  • 미국  브라운대학  간연구소  박사후  과정  (2001-2003)
  • 호주  멜번대학  빅토리아  감염병  연구소  교환교수  (2008-2009)   
  • 대외활동]
  • 주요  다기관  전향적  임상연구  수행  (총  80개,  연구책임자  50개)
  • 300여  개의  SCI  국제논문  발표 
  • 연구책임자로  정부  과제  수행  (보건복지부,  교육과학부,  지식경제부)
  • 보건복지부  질병관리본부  간염분과  자문위원  (2013-현재)
  • 식품의약품안전평가원  의약품  심사자문단  (2014-현재)
  • 식품의약품안전처  중앙약사심의위원회  전문가  (2014-현재)
  • 한국의약품안전관리원  DUR  분과위원  (2019.1~현재)
  • 한국보건의료연구원  신의료기술평가사업  자문위원  (2013-현재)
  • 헬스경향  [간(肝)편한세상]  칼럼연제  (2015-2017)
  • EBS  [명의]  선정  (2017),  월간조선  [신(新)명의]  선정(2017)
  •   [해외연수]
  • 미국  브라운대학  간연구소  박사후  과정  수료  (2001-2003)
  • 호주  멜번대학  빅토리아  감염연구소  (VIDRL)  연수  (2008-2009)

학술관련경력

  • 대한간학회 학술이사 (2018-현재)
  • 대한간학회 홍보이사 역임 (2014-2015)
  • 아시아 태평양 간암학회 (APPLE) 학술위원장 역임 (2013)
  • 대한간암연구학회 학술위원장 역임 (2010-2011)
  • 국제논문 편집장: 아태간학회지 (JGH)), PLoS ONE, Gut and Liver
  • 국제논문 편집위원: 유럽간학회지 (Journal of Hepatology), 세계간학회지 (Liver International)
  • 국제논문 검토위원: NEJM, Lancet, Gastroenterology, Gut, Hepatology 등 20여개

주요 관심분야

  • 바이러스성 간염(분자생물학, 신약개발, 약제내성치료)
  • 간경변증, 간암(병태생리, 신치료)

학력사항

  • 연세대학교 의학과 학사(1995), 석사(1998) 박사(2003)
  • 연세대학교 경영대학원 mini-MBA 수료
  • 다국적 제약회사 신약개발 국제자문위원

논문

  • Feasibility of dynamic risk assessment for patients with repeated trans-arterial chemoembolization for hepatocellular carcinoma
    BMC CANCER 19/363 :-,2019
  • Refractoriness to transarterial chemoembolization in patients with recurrent hepatocellular carcinoma after curative resection
    PLOS ONE 14/4 :e0214613-,2019
  • Predictors of Discordance in the Assessment of Skeletal Muscle Mass between Computed Tomography and Bioimpedance Analysis
    Journal of Clinical Medicine 7/8 :3-,2019
  • Psychometric evaluation of the Korean version of the Hepatitis B Quality of Life Questionnaire
    PLOS ONE 14/2 :e0213001-,2019
  • Follow-Up Liver Stiffness Measurements after Liver Resection Influence Oncologic Outcomes of Hepatitis-B-Associated Hepatocellular Carcinoma with Liver Cirrhosis
    Cancers 11/3 : E425-,2019
  • Comparison between chronic hepatitis B patients with untreated immune-tolerant phase vs. those with virological response by antivirals
    SCIENTIFIC REPORTS 9/1 :2,508-,2019
  • Fibrosis-matched outcomes between chronic hepatitis B patients with drug-induced virological response and inactive carriers
    LIVER INTERNATIONAL 39/1 :81-89,2019
  • Liver Fibrosis, Not Steatosis, Associates with Long-Term Outcomes in Ischaemic Stroke Patients
    CEREBROVASCULAR DISEASES 47/1-2 :32-39,2019
  • 96 weeks treatment of tenofovir alafenamide vs. tenofovir disoproxil fumarate for hepatitis B virus infection
    JOURNAL OF HEPATOLOGY 68/4 :672-681,2018
  • The effect of interferon-free regimens on health-related quality of life in East Asian patients with chronic hepatitis C
    LIVER INTERNATIONAL 38/7 :1,179-1,187,2018
  • Sofosbuvir and ledipasvir are associated with high sustained virologic response and improvement of health-related quality of life in East Asian patients with hepatitis C virus infection
    JOURNAL OF VIRAL HEPATITIS 25/12 :1,429-1,437,2018
  • Safety, efficacy and pharmacodynamics of vesatolimod (GS-9620) in virally suppressed patients with chronic hepatitis B
    JOURNAL OF HEPATOLOGY 68/3 :431-440,2018
  • A novel risk score for hepatocellular carcinoma in Asian cirrhotic patients: a multicentre prospective cohort study
    SCIENTIFIC REPORTS 8/1 :8,608-,2018
  • Hepatitis B Surface Antigen Loss with Tenofovir Disoproxil Fumarate Plus Peginterferon Alfa-2a: Week 120 Analysis
    DIGESTIVE DISEASES AND SCIENCES 63/12 :3,487-3,497,2018
  • A quantile regression approach to explain the relationship of Fatigue and Cortisol, Cytokine among Koreans with Hepatitis B
    SCIENTIFIC REPORTS 8/ :16,434-16,441,2018
  • Reproducibility of European Association for the Study of the Liver criteria and modified Response Evaluation Criteria in Solid Tumors in patients treated with sorafenib
    LIVER INTERNATIONAL 38/9 :1,655-1,663,2018
  • Sarcopenia is associated with the risk of significant liver fibrosis in metabolically unhealthy subjects with chronic hepatitis B
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS 48/3 :300-312,2018
  • HBsAg-negative and anti-HBc-positive in eosinophilic granulomatosis with polyangiitis: a retrospective pilot study
    RHEUMATOLOGY INTERNATIONAL 38/8 :1,531-1,538,2018
  • Feasibility of dynamic risk prediction for hepatocellular carcinoma development in patients with chronic hepatitis B
    LIVER INTERNATIONAL 38/4 :676-686,2018
  • Daclatasvir Plus Asunaprevir for the Treatment of Patients with Hepatitis C Virus Genotype 1b Infection: Real-World Efficacy, Changes in Liver Stiffness and Fibrosis Markers, and Safety
    GUT AND LIVER 12/3 :324-330,2018
  • Tumor Necrosis Factor-producing T-regulatory Cells Are Associated With Severe Liver Injury in Patients With Acute Hepatitis A
    GASTROENTEROLOGY 154/4 :1,047-1,060,2018
  • Predictors of failure to detect early hepatocellular carcinoma in patients with chronic hepatitis B who received regular surveillance
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS 47/8 :1,201-1,212,2018
  • Switching from tenofovir and nucleoside analogue therapy to tenofovir monotherapy in virologically suppressed chronic hepatitis B patients with antiviral resistance
    JOURNAL OF MEDICAL VIROLOGY 90/3 :497-502,2018
  • Combination of Transient Elastography and an Enhanced Liver Fibrosis Test to Assess the Degree of Liver Fibrosis in Patients with Chronic Hepatitis B
    GUT AND LIVER 12/2 :190-200,2018
  • Reduced risk of hepatocellular carcinoma by achieving a subcirrhotic liver stiffness through antiviral agents in hepatitis B virus?related advanced fibrosis or cirrhosis
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY 33/2 :503-510,2018
  • Prevalence and Predictors of Significant Fibrosis Among Subjects with Transient Elastography-Defined Nonalcoholic Fatty Liver Disease
    DIGESTIVE DISEASES AND SCIENCES 62/8 :2,150-2,158,2017
  • Sequence analysis and functional characterization of full-length hepatitis B virus genomes from Korean cirrhotic patients with or without liver cancer
    VIRUS RESEARCH 235/Speci :86-95,2017
  • Daclatasvir/asunaprevir/beclabuvir, all-oral, fixed-dose combination for patients with chronic hepatitis C virus genotype 1
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY 32/12 :1,998-2,005,2017
  • Validation of the PAGE-B Model in Asian Chronic Hepatitis B Patients Receiving Entecavir or Tenofovir
    LIVER INTERNATIONAL 37/12 :1788-1795,2017
  • Survival Estimates after Stopping Sorafenib in Patients with Hepatocellular Carcinoma: NEXT Score Development and Validation
    GUT AND LIVER 11/5 :693-701,2017
  • Effects of Entecavir and Tenofovir on Renal Function in Patients with Hepatitis B Virus-Related Compensated and Decompensated Cirrhosis
    GUT AND LIVER 11/6 :828-834,2017
  • Dickkopf-1 induces angiogenesis via VEGF receptor 2 regulation independent of the Wnt signaling pathway
    ONCOTARGET 8/35 :58,974-58,984,2017
  • Conditional survival estimate in patients with Barcelona Clinic Liver Cancer stage B/C hepatocellular carcinoma treated with hepatic arterial infusion chemotherapy with/without concurrent radiotherapy
    ONCOTARGET 8/45 :79,914-79,926,2017
  • Management of Clevudine-Resistant Chronic Hepatitis B: A Multicenter Cohort Study
    GUT AND LIVER 11/1 :129-135,2017
  • Gene Expression Profiling of Hepatocellular Carcinoma Derived Cancer Stem Like Cell under Hypoxia
    YONSEI MEDICAL JOURNAL 58/5 :925-933,2017
  • Wisteria floribunda agglutinin-positive human Mac-2 binding protein predicts the risk of HBV-related liver cancer development
    LIVER INTERNATIONAL 37/6 :879-887,2017
  • Urgency to treat patients with chronic hepatitis C in Asia
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY 32/5 :966-974,2017
  • Less fibrotic burden differently affects the long-term outcomes of hepatocellular carcinoma after curative resection
    ONCOLOGY 93/4 :224-232,2017
  • Transarterial Radioembolization Versus Concurrent Chemoradiation Therapy for Locally Advanced Hepatocellular Carcinoma: A Propensity Score Matching Analysis
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS 99/2 :396-406,2017
  • Long-Term Follow-Up of Patients after Autologous Bone Marrow Cell Infusion for Decompensated Liver Cirrhosis
    CELL TRANSPLANTATION 26/6 :1,059-1,066,2017
  • Acute hepatitis A, B, and C but not D is still prevalent in Mongolia: a time trend analysis
    Clinical and molecular hepatology 23/2 :147-153,2017
  • Using transient elastography to predict hepatocellular carcinoma recurrence after radiofrequency ablation
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY 32/5 :1,079-1,086,2017
  • Gamma-glutamyl transpeptidase-to-platelet ratio is an independent predictor of hepatitis B virus-related liver cancer
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY 32/6 :1,221-1,229,2017
  • Liver fibrosis assessed with transient elastography is an independent risk factor for ischemic stroke
    ATHEROSCLEROSIS 260/ :156-162,2017
  • Subcirrhotic liver stiffness by FibroScan correlates with lower risk of hepatocellular carcinoma in patients with HBV-related cirrhosis
    HEPATOLOGY INTERNATIONAL 11/3 :268-276,2017
  • Fatty liver associated with metabolic derangement in patients with chronic kidney disease: A controlled attenuation parameter study.
    Kidney Research and Clinical Practice 36/1 :48-57,2017
  • Improvement of Liver Fibrosis after Long-Term Antiviral Therapy Assessed by Fibroscan in Chronic Hepatitis B Patients With Advanced Fibrosis
    AMERICAN JOURNAL OF GASTROENTEROLOGY 112/6 :882-891,2017
  • Prognostic factors of sorafenib therapy in hepatocellular carcinoma patients with failure of transarterial chemoembolization
    HEPATOLOGY INTERNATIONAL 11/3 :292-299,2017
  • Rituximab and hepatitis B reactivation in HBsAg-negative/anti-HBc-positive kidney transplant recipients
    NEPHROLOGY DIALYSIS TRANSPLANTATION 32/4 :722-729,2017
  • Conventional versus drug-eluting beads chemoembolization for hpeatocellular carcinoma: Emphasis on the impact of tumor size
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY 32/2 :487-496,2017
  • Tenofovir versus tenofovir plus entecavir for chronic hepatitis B with lamivudine resistance and entecavir resistance
    JOURNAL OF VIRAL HEPATITIS 24/2 :141-147,2017
  • Durability of the virological response after lamivudine discontinuation in lamivudine-resistant patients with a complete virological response after lamivudine and adefovir combination therapy
    JOURNAL OF MEDICAL VIROLOGY 89/1 :85-90,2017
  • Cell culture-adaptive mutations of NS5A affect replication of hepatitis C virus differentially depending on the viral genotypes
    JOURNAL OF MEDICAL VIROLOGY 89/1 :146-152,2017
  • Knockdown of HIF-1 alpha and IL-8 induced apoptosis of hepatocellular carcinoma triggers apoptosis of vascular endothelial cells
    APOPTOSIS 21/1 :85-95,2016
  • Chronic Hepatitis B Virus Infection Disease Revisit and Management Recommendations
    JOURNAL OF CLINICAL GASTROENTEROLOGY 50/4 :286-294,2016
  • A 96-week randomized trial of switching to entecavir in patients who achieved virological suppression on lamivudine therapy
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY 31/4 :865-871,2016
  • A phase 3b study of sofosbuvir plus ribavirin in treatment-naive and treatment-experienced Korean patients chronically infected with genotype 2 hepatitis C virus
    JOURNAL OF VIRAL HEPATITIS 23/5 :358-365,2016
  • The clinical implication of single nucleotide polymorphisms in deoxycytidine kinase in chronic hepatitis B patients treated with lamivudine
    JOURNAL OF MEDICAL VIROLOGY 88/5 :820-827,2016
  • Prediction models of hepatocellular carcinoma development in chronic hepatitis B patients
    WORLD JOURNAL OF GASTROENTEROLOGY 22/37 :8,314-8,321,2016
  • All-oral daclatasvir plus asunaprevir for chronic hepatitis C virus (HCV) genotype 1b infection: a sub-analysis in Asian patients from the HALLMARK DUAL study
    LIVER INTERNATIONAL 36/10 :1,433-1,441,2016
  • Chronic Hepatitis B Virus Infection Disease: Revisit and Management Recommendations
    JOURNAL OF CLINICAL GASTROENTEROLOGY 50/4 :286-294,2016
  • Association Between Level of Fibrosis, Rather Than Antiviral Regimen, and Outcomes of Patients With Chronic Hepatitis B
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY 14/11 :1,647-1,647,2016
  • An Observational, Multicenter, Cohort Study Evaluating the Antiviral Efficacy and Safety in Korean Patients with Chronic Hepatitis B Receiving Pegylated Interferon-Alpha 2a (Pegasys)
    MEDICINE 95/14 :e3026-,2016
  • Efficacy of switching from adefovir to tenofovir in chronic hepatitis B patients who exhibit suboptimal responses to adefovir-based combination rescue therapy due to resistance to nucleoside analogues (SATIS study)
    Clinical and molecular hepatology 22/4 :443-449,2016
  • A phase IIIb study of ledipasvir/sofosbuvir fixed-dose combination tablet in treatment-na < ve and treatment-experienced Korean patients chronically infected with genotype 1 hepatitis C virus
    HEPATOLOGY INTERNATIONAL 10/6 :947-955,2016
  • Toll-IL1 receptor-mediated innate immune responses vary across HBV genotype and predict treatment response to pegylated-IFN in HBeAg-positive CHB patients
    JOURNAL OF VIRAL HEPATITIS 23/3 :170-179,2016
  • Hepatitis C virus and antiviral drug resistance
    GUT AND LIVER 10/6 :890-895,2016
  • Clinical Utility of a New Automated Hepatitis C Virus Core Antigen Assay for Prediction of Treatment Response in Patients with Chronic Hepatitis C
    JOURNAL OF KOREAN MEDICAL SCIENCE 31/9 :1,431-1,437,2016
  • Peginterferon lambda for the treatment of HBeAg-positive chronic hepatitis B: A randomized phase 2b study (LIRA-B)
    JOURNAL OF HEPATOLOGY 64/5 :1,011-1,019,2016
  • Combination of Tenofovir Disoproxil Fumarate and Peginterferon alpha-2a Increases Loss of Hepatitis B Surface Antigen in Patients With Chronic Hepatitis B
    GASTROENTEROLOGY 150/1 :134-134,2016
  • Clinical outcomes and predictors for relapse after cessation of oral antiviral treatment in chronic hepatitis B patients
    JOURNAL OF GASTROENTEROLOGY 51/8 :830-839,2016
  • Entecavir plus tenofovir combination therapy in patients with multidrug-resistant chronic hepatitis B: results of a multicentre, prospective study
    LIVER INTERNATIONAL 36/8 :1108-1115,2016
  • Predictive Factors of Spontaneous Bacterial Peritonitis Caused by Gram-Positive Bacteria in Patients With Cirrhosis
    MEDICINE 95/17 :e3489-,2016
  • Incidence and risk factors of delayed postpolypectomy bleeding in patients with chronic liver disease
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY 51/5 :618-624,2016
  • The Relationship between Type 2 Diabetes Mellitus and Non-Alcoholic Fatty Liver Disease Measured by Controlled Attenuation Parameter
    YONSEI MEDICAL JOURNAL 57/4 :885-892,2016
  • Clinical predictors of silent but substantial liver fibrosis in primary Sjogren's syndrome.
    MODERN RHEUMATOLOGY 26/4 :576-582,2016
  • Transient Elastography is Superior to FIB-4 in Assessing the Risk of Hepatocellular Carcinoma in Patients With Chronic Hepatitis B
    MEDICINE 95/20 :e3434-,2016
  • Subclassification of Barcelona Clinic Liver Cancer B and C hepatocellular carcinoma: A cohort study of the multicenter registry database
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY 31/4 :842-847,2016
  • Predicting Liver-Related Events Using Transient Elastography in Chronic Hepatitis C Patients with Sustained Virological Response
    GUT AND LIVER 10/3 :429-436,2016
  • Use of Wisteria Floribunda Agglutinin-Positive Human Mac-2 Binding Protein in Assessing Risk of Hepatocellular Carcinoma Due to Hepatitis B Virus
    MEDICINE 95/14 :e3328-,2016
  • An evaluation of entecavir for the treatment of chronic hepatitis B infection in adults
    EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY 10/2 :177-186,2016
  • Prediction of Virologic Response to Tenofovir Mono-Rescue Therapy for Multidrug Resistant Chronic Hepatitis B
    JOURNAL OF MEDICAL VIROLOGY 88/6 :1027-1034,2016
  • Factors Influencing the Diagnostic Accuracy of Acoustic Radiation Force Impulse Elastography in Patients with Chronic Hepatitis B
    GUT AND LIVER 10/2 :275-282,2016
  • Risk prediction for patients with hepatocellular carcinoma undergoing chemoembolization: development of a prediction model.
    LIVER INTERNATIONAL 36/1 :92-99,2016
  • Red cell volume distribution width-to-platelet ratio in assessment of liver fibrosis in patients with chronic hepatitis B
    LIVER INTERNATIONAL 36/1 :24-30,2016
  • Addition of tumor multiplicity improves the prognostic performance of the hepatoma arterial-embolization prognostic score
    LIVER INTERNATIONAL 36/1 :100-107,2016
  • Outcome of adefovir add-on lamivudine rescue therapy of up to 5?years in patients with lamivudine-resistant chronic hepatitis B.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY 31/1 :241-247,2016
  • Sarcopenia Is Associated With Significant Liver Fibrosis Independently of Obesity and Insulin Resistance in Nonalcoholic Fatty Liver Disease: Nationwide Surveys (KNHANES 2008-2011)
    HEPATOLOGY 63/3 :776-786,2016
  • Development of a transgenic mouse model of hepatocellular carcinoma with a liver fibrosis background
    BMC GASTROENTEROLOGY 16/13 :1-9,2016
  • Knockdown of HIF-1a and IL-8 induced apoptosis of hepatocellular carcinoma triggers apoptosis of vascular endothelial cells
    APOPTOSIS 21/1 :85-95,2016
  • Combined use of AFP, PIVKA-II, and AFP-L3 as tumor markers enhances diagnostic accuracy for hepatocellular carcinoma in cirrhotic patients
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY 51/3 :344-353,2016
  • Liver stiffness-based model for prediction of hepatocellular carcinoma in chronic hepatitis B virus infection: comparison with histological fibrosis
    LIVER INTERNATIONAL 35/3 :1054-1062,2015
  • Growth rate of early-stage hepatocellular carcinoma in patients with chronic liver disease
    Clinical and molecular hepatology 21/3 :279-286,2015
  • Validation of Hepatitis B Virus-Related Hepatocellular Carcinoma Prediction Models in the Era of Antiviral Therapy
    HEPATOLOGY 62/6 :1757-1766,2015
  • Analysis of miRNA expression patterns in human and mouse hepatocellular carcinoma cells
    HEPATOLOGY RESEARCH 45/13 :1331-1340,2015
  • Comparison of the Effects of Telbivudine and Entecavir Treatment on Estimated Glomerular Filtration Rate in Patients with Chronic Hepatitis B
    GUT AND LIVER 9/6 :776-783,2015
  • Clonal evolution of multidrug resistant hepatitis B virus during entecavir rescue therapy
    LIVER INTERNATIONAL 35/11 :2370-2383,2015
  • Prevention of Hepatocellular Carcinoma: Beyond Hepatitis B Vaccination
    SEMINARS IN ONCOLOGY 42/2 :316-328,2015
  • High Sustained Virologic Response to Daclatasvir Plus Asunaprevir in Elderly gh Sustained Virologic Response to Daclatasvir Plus Asunaprevir in Elderly and Cirrhotic Patients with Hepatitis C Virus Genotype 1b Without Baseline NS5A Polymorphisms
    ADVANCES IN THERAPY 32/7 :637-649,2015
  • Relationship between Cerebral Microbleeds and Liver Stiffness Determined by Transient Elastography
    PLOS ONE 10/9 :e0139227-,2015
  • Substitution at rt269 in Hepatitis B Virus Polymerase Is a Compensatory Mutation Associated with Multi-Drug Resistance
    PLOS ONE 10/8 :1-17,2015
  • Probability-Based Interpretation of Liver Stiffness Measurement in Untreated Chronic Hepatitis B Patients
    DIGESTIVE DISEASES AND SCIENCES 60/5 :1448-1456,2015
  • Serum Dickkopf-1 as a Biomarker for the Diagnosis of Hepatocellular Carcinoma
    YONSEI MEDICAL JOURNAL 56/5 :1296-1306,2015
  • Hepatic fibrosis assessed using transient elastography independently associated with coronary artery calcification
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY 30/10 :1536-1542,2015
  • Disease duration and Medsger’s severity score are associated with significant liver fibrosis in patients with systemic sclerosis
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY Suppl. 91 :S68-S74,2015
  • Inter-observer variability of response evaluation criteria for hepatocellular carcinoma treated with chemoembolization
    DIGESTIVE AND LIVER DISEASE 47/8 :682-688,2015
  • Two-year treatment outcome of chronic hepatitis B infection treated with besifovir vs. entecavir: Results from a multicentre study
    JOURNAL OF HEPATOLOGY 62/3 :526-532,2015
  • Prognostic role of magnetic resonance imaging vs. computed tomography for hepatocellular carcinoma undergoing chemoembolization
    LIVER INTERNATIONAL 35/6 :1722-1730,2015
  • Complete response at first chemoembolization is still the most robust predictor for favorable outcome in hepatocellular carcinoma
    JOURNAL OF HEPATOLOGY 62/6 :1304-1310,2015
  • Increased Risk of Hepatocellular Carcinoma in Chronic Hepatitis B Patients With Transient Elastography-Defined Subclinical Cirrhosis
    HEPATOLOGY 61/6 :1851-1859,2015
  • A Novel Model to Predict Esophageal Varices in Patients with Compensated Cirrhosis Using Acoustic Radiation Force Impulse Elastography
    PLOS ONE 10/3 :e0121009-,2015
  • Prognostic value of the combined use of transient elastography and fibrotest in patients with chronic hepatitis B
    LIVER INTERNATIONAL 35/2 :455-462,2015
  • Normal controlled attenuation parameter values: a prospective study of healthy subjects undergoing health checkups and liver donors in Korea
    DIGESTIVE DISEASES AND SCIENCES 60/1 :234-242,2015
  • Use of transient elastography to predict de novo recurrence after radiofrequency ablation for hepatocellular carcinoma
    ONCOTARGETS AND THERAPY 8/ :347-356,2015
  • Factors associated with significant liver fibrosis assessed using transient elastography in general population
    WORLD JOURNAL OF GASTROENTEROLOGY 21/Issue :1158-1166,2015
  • Lower incidence of hepatocellular carcinoma and cirrhosis in hepatitis C patients with sustained virologic response by pegylated interferon and ribavirin
    DIGESTIVE DISEASES AND SCIENCES 60/2 :573-581,2015
  • Reimbursement policies in the Asia-Pacific for chronic hepatitis B
    HEPATOLOGY INTERNATIONAL 9/1 :43-51,2015
  • Spontaneous HBsAg loss in Korean patients: relevance of viral genotypes, S gene mutations, and covalently closed circular DNA copy numbers
    Clinical and molecular hepatology 20/3 :251-260,2014
  • Downregulation of Interleukin-18-Mediated Cell Signaling and Interferon Gamma Expression by the Hepatitis B Virus e Antigen
    JOURNAL OF VIROLOGY 88/18 :10,412-10,420,2014
  • New Susceptibility and Resistance HLA-DP Alleles to HBV-Related Diseases Identified by a Trans-Ethnic Association Study in Asia
    PLOS ONE 9/2 :e86449-e86455,2014
  • Individual prediction model for lamivudine treatment response in hepatitis B virus e antigen-positive chronic hepatitis B patients
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY 29/5 :1049-1055,2014
  • Silencing of hypoxia-inducible factor-1β induces anti-tumor effects in hepatoma cell lines under tumor hypoxia.
    PLOS ONE 9/7 :e103304-,2014
  • Inhibition of tumour angiogenesis and growth by small hairpin HIF-1a and IL-8 in hepatocellular carcinoma
    LIVER INTERNATIONAL 34/4 :632-642,2014
  • Maintaining remission in lamivudine-resistant patients with a virological response to adefovir add-on lamivudine after stopping lamivudine therapy
    LIVER INTERNATIONAL 34/10 :1543-1549,2014
  • Entecavir plus adefovir versus adefovir plus lamivudine in hepatitis B virus e antigen-positive, lamivudine-resistant chronic hepatitis B
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY 29/7 :1485-1493,2014
  • Casein Kinase II Inhibitor Enhances Production of Infectious Genotype 1a Hepatitis C Virus (H77S)
    PLOS ONE 9/12 :e113938-,2014
  • Risk assessment of clinical outcomes in Asian patients with chronic hepatitis B using enhanced liver fibrosis test
    HEPATOLOGY 60/6 :1911-1919,2014
  • Lesson from 610 liver resections of hepatocellular carcinoma in a single center over 10 years
    WORLD JOURNAL OF SURGICAL ONCOLOGY 12/192 :1-9,2014
  • Tenofovir disoproxil fumarate monotherapy for nucleos(t)ide-naive chronic hepatitis B patients in Korea
    Clinical and molecular hepatology 20/3 :261-266,2014
  • Emerging therapies for hepatitis C
    GUT AND LIVER 8/5 :471-479,2014
  • Surgical Resection After Down-Staging of Locally Advanced Hepatocellular Carcinoma by Localized Concurrent Chemoradiotherapy
    ANNALS OF SURGICAL ONCOLOGY 21/11 :3646-3653,2014
  • Clinical outcomes and prognostic factors of patients with advanced hepatocellular carcinoma treated with sorafenib as first-line therapy: A Korean multicenter study
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY 29/7 :1463-1469,2014
  • Prediction of development of liver-related events by transient elastography in Hepatitis B patients with complete virological response on antiviral therapy
    AMERICAN JOURNAL OF GASTROENTEROLOGY 109/8 :1241-1249,2014
  • Long-term changes of liver stiffness values assessed using transient elastography in patients with chronic hepatitis B receiving entecavir
    LIVER INTERNATIONAL 34/8 :1216-1223,2014
  • Histological subclassification of cirrhosis can predict recurrence after curative resection of hepatocellular carcinoma
    LIVER INTERNATIONAL 34/7 :1008-1017,2014
  • Impact of Spontaneous Hepatocellular Carcinoma Rupture on Recurrence Pattern and Long-term Surgical Outcomes after Partial Hepatectomy
    WORLD JOURNAL OF SURGERY 38/8 :2070-2078,2014
  • Prognostic Indicators for Acute Liver Failure Development and Mortality in Patients with Hepatitis A: Consecutive Case Analysis
    YONSEI MEDICAL JOURNAL 55/4 :953-959,2014
  • New Susceptibility and Resistance HLA-DP Alleles to HBV-Related Diseases Identified by a Trans-Ethnic Association Study in Asia
    PLOS ONE 9/Issue 2 :e86449-,2014
  • Long-term outcomes of chronic hepatitis B virus infection in the era of antiviral therapy in Korea
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY 29/5 :1005-1011,2014
  • Pre-S mutations of hepatitis B virus affect genome replication and expression of surface antigens
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY 29/4 :843-850,2014
  • Phase IIb multicentred randomised trial of besifovir (LB80380) versus entecavir in Asian patients with chronic hepatitis B
    GUT 63/6 :996-1004,2014
  • Liver Stiffness Value-Based Risk Estimation of Late Recurrence after Curative Resection of Hepatocellular Carcinoma: Development and Validation of a Predictive Model
    PLOS ONE 9/6 :e99167-,2014
  • Factors Affecting the Accuracy of Controlled Attenuation Parameter (CAP) in Assessing Hepatic Steatosis in Patients with Chronic Liver Disease
    PLOS ONE 9/6 :e98689-,2014
  • Prognosis of hepatocellular carcinoma patients with extrahepatic metastasis and the controllability of intrahepatic lesions
    CLINICAL & EXPERIMENTAL METASTASIS 31/4 :475-482,2014
  • Dynamics of the Liver Stiffness Value Using Transient Elastography during the Perioperative Period in Patients with Valvular Heart Disease
    PLOS ONE 9/Issue 3 :e92795-,2014
  • Non-invasive prediction of forthcoming cirrhosis-related complications
    WORLD JOURNAL OF GASTROENTEROLOGY 20/10 :2613-2623,2014
  • Relationship Between Severity of Liver Dysfunction and the Relative Ratio of Liver to Aortic Enhancement (RE) on MRI Using Hepatocyte-Specific Contrast
    JOURNAL OF MAGNETIC RESONANCE IMAGING 39/1 :24-30,2014
  • Risk Assessment of Liver-related Events Using Transient Elastography in Patients With Chronic Hepatitis B Receiving Entecavir
    JOURNAL OF CLINICAL GASTROENTEROLOGY 48/3 :272-278,2014
  • Clinical usefulness of double biomarkers AFP and PIVKA-II for subdividing prognostic groups in locally advanced hepatocellular carcinoma
    LIVER INTERNATIONAL 34/2 :313-321,2014
  • Use of the Delta Neutrophil Index as a Prognostic Factor of Mortality in Patients with Spontaneous Bacterial Peritonitis: Implications of a Simple and Useful Marker
    PLOS ONE 9/1 :e86884-,2014
  • Controlled attenuation parameter (CAP) for detection of hepatic steatosis in patients with chronic liver diseases: a prospective study of a native Korean population
    LIVER INTERNATIONAL 34/1 :102-109,2014
  • Efficacy of switching to telbivudine plus adefovir in suboptimal responders to lamivudine plus adefovir
    WORLD JOURNAL OF GASTROENTEROLOGY 19/43 :7,671-7,679,2013
  • Quasispecies and Pre-Existing Drug-Resistant Mutations of Hepatitis B Virus in Patients with Chronic Hepatitis B
    GUT AND LIVER 7/3 :329-334,2013
  • Two cases of telbivudine-induced myopathy in siblings with chronic hepatitis B
    Clinical and Molecular Hepatology 19/1 :82-86,2013
  • Survival of Hepatocellular Carcinoma Patients May be Improved in Surveillance Interval not More Than 6 Months Compared With More Than 6 Months: A 15-Year Prospective Study
    JOURNAL OF CLINICAL GASTROENTEROLOGY 47/6 :538-544,2013
  • Abnormal Liver Stiffness Assessed Using Transient Elastography (Fibroscan (R)) in HIV-Infected Patients without HBV/HCV Coinfection Receiving Combined Antiretroviral Treatment
    PLOS ONE 8/1 :e52720-e52727,2013
  • Treatment of lamivudine-resistant chronic hepatitis B infection: a multicenter retrospective study
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY 48/ :196-204,2013
  • Clinical features of autoimmune hepatitis and comparison of two diagnostic criteria in Korea: A nationwide, multicenter study
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY 28/1 :128-134,2013
  • Predictors of Refractory Ascites Development in Patients with Hepatitis B Virus-Related Cirrhosis Hospitalized to Control Ascitic Decompensation
    YONSEI MEDICAL JOURNAL 54/ :145-153,2013
  • Prognostic Value of Model for End-Stage Liver Disease Scores in Patients with Fulminant Hepatic Failure
    TRANSPLANTATION PROCEEDINGS 45/8 :2992-2994,2013
  • Influence of Hepatic Dysfunction on the Pharmacokinetics and Safety of Fimasartan
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY 62/6 :524-529,2013
  • Predictors of Refractory Ascites Development in Patients with Hepatitis B Virus-Related Cirrhosis Hospitalized to Control Ascitic Decompensation
    YONSEI MEDICAL JOURNAL 54/1 :145-153,2013
  • Performance evaluation of the HepB Typer-Entecavir kit for detection of entecavir resistance mutations in chronic hepatitis B
    Clinical and Molecular Hepatology 19/4 :399-408,2013
  • Efficary of switching to telbivudine pius adefovir in suboptimal responders to lamivudine plus adefovir
    WORLD JOURNAL OF GASTROENTEROLOGY 19/43 :7671-7679,2013
  • Antiviral efficacies of currently available rescue therapies for multidrug-resistant chronic hepatitis B
    Clinical and Molecular Hepatology 19/1 :29-35,2013
  • Role of splenectomy in patients with hepatocellular carcinoma and hypersplenism
    ANZ JOURNAL OF SURGERY 83/11 :865-870,2013
  • Efficacy of Sorafenib Monotherapy versus Sorafenib-Based Loco-Regional Treatments in Advanced Hepatocellular Carcinoma
    PLOS ONE 8/10 :e77240-,2013
  • Transient elastography-based risk estimation of hepatitis B virus-related occurrence of hepatocellular carcinoma: development and validation of a predictive model
    ONCOTARGETS AND THERAPY 6/- :1463-1469,2013
  • Prognostic significance of the worst grade in hepatocellular carcinoma with heterogeneous histologic grades of differentiation
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY 28/8 :1384-1390,2013
  • Antibody-Secreting Cells with a Phenotype of Ki-67(low), CD138(high), CD31(high), and CD38(high) Secrete Nonspecific IgM during Primary Hepatitis A Virus Infection
    JOURNAL OF IMMUNOLOGY 191/1 :127-134,2013
  • Orthotopic liver transplantation after the combined use of locoregional therapy and sorafenib for advanced hepatocellular carcinoma
    ONCOTARGETS AND THERAPY 6/ :755-759,2013
  • Association between IL28B Polymorphisms and Spontaneous Clearance of Hepatitis B Virus Infection
    PLOS ONE 8/7 :e69166-e69166,2013
  • Survival of hepatocellular carcinoma patients may be improved in surveillance interval not more than 6 months compared with more than 6 months; A 15-year prospective study
    JOURNAL OF CLINICAL GASTROENTEROLOGY 47/6 :538-544,2013
  • Quasispecies and Pre-Existing Drug-Resistant Mutations of Hepatitis B Virus in Patients with Chronic Hepatitis B
    GUT AND LIVER 7/3 :329-334,2013
  • Partial Virological Response to Adefovir Add-On Lamivudine Rescue Therapy in Patients with Lamivudine-Resistant Chronic Hepatitis B
    DIGESTION 87/3 :196-203,2013
  • Number of target lesions for EASL and modified RECIST to predict survivals in hepatocellular carcinoma treated with chemoembolization
    CLINICAL CANCER RESEARCH 19/6 :1503-1511,2013
  • Normal enhanced liver fibrosis (ELF) values in apparently healthy subjects undergoing a health check-up and in living liver donors in South Korea
    LIVER INTERNATIONAL 33/5 :706-713,2013
  • Characterization of focal liver masses using acoustic radiation force impulse elastography
    WORLD JOURNAL OF GASTROENTEROLOGY 19/2 :219-226,2013
  • Investigation of Oncogenic Cooperation in Simple Liver-Specific Transgenic Mouse Models Using Noninvasive In Vivo Imaging
    PLOS ONE 8/3 :e59869-e59869,2013
  • The use of health functional foods in gastrointestinal cancer patients
    Clinical nutrition research 2/1 :19-25,2013
  • Early Predictor of Mortality due to Irreversible Posthepatectomy Liver Failure in Patients with Hepatocellular Carcinoma
    WORLD JOURNAL OF SURGERY 37/ :1028-1033,2013
  • Prospective comparison of prognostic values of modified Response Evaluation Criteria in Solid Tumours with European Association for the Study of the Liver criteria in hepatocellular carcinoma following chemoembolisation
    EUROPEAN JOURNAL OF CANCER 49/4 :826-834,2013
  • Early on-treatment change in liver stiffness predicts development of liver-related events in chronic hepatitis B patients receiving antiviral therapy
    LIVER INTERNATIONAL 33/2 :180-189,2013
  • Discordance between Liver Biopsy and FibroTest in Assessing Liver Fibrosis in Chronic Hepatitis B
    PLOS ONE 8/2 :e55759-e55759,2013
  • A Novel Estimation of the Relative Economic Value in Terms of Different Chronic Hepatitis B Treatment Options
    PLOS ONE 8/3 :e57900-e57900,2013
  • Prognostic value of α-fetoprotein and des-γ-carboxy prothrombin responses in patients with hepatocellular carcinoma treated with transarterial chemoembolization
    BMC CANCER 13/5 :1-10,2013
  • Abnormal Liver Stiffness Assessed Using Transient Elastography (Fibroscan) in HIV-Infected Patients without HBV/HCV Coinfection Receiving Combined Antiretroviral Treatment
    PLOS ONE 8/1 :e52720-e52720,2013
  • Combination treatment of localized concurrent chemoradiation therapy and transarterial chemoembolization in locally advanced hepatocellular carcinoma with intrahepatic metastasis
    CANCER CHEMOTHERAPY AND PHARMACOLOGY 71/1 :165-173,2013
  • Telbivudine in combination with adefovir versus adefovir monotherapy in HBeAg-positive, lamivudine-resistant chronic hepatitis B
    HEPATOLOGY INTERNATIONAL 6/4 :696-706,2012
  • Clinical features and prognosis of hepatocellular carcinoma in Mongolia: a multicentre study
    HEPATOLOGY INTERNATIONAL 6/ :763-769,2012
  • A 96-week randomized trial of switching to entecavir in chronic hepatitis B patients with a partial virological response to lamivudine
    ANTIVIRAL THERAPY 17/8 :1563-1570,2012
  • Prediction of Recurrence after Curative Resection of Hepatocellular Carcinoma using Liver Stiffness Measurement (FibroScan ?)
    ANNALS OF SURGICAL ONCOLOGY 19/13 :4278-4286,2012
  • Transient elastography in real practice: A time for action?
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY 27/7 :1134-1135,2012
  • Performance of Transient Elastography for the Staging of Liver Fibrosis in Patients with Chronic Hepatitis B: A Meta-Analysis
    PLOS ONE 7/9 :e44930-,2012
  • No association for Chinese HBV-related hepatocellular carcinoma susceptibility SNP in other East Asian populations
    BMC MEDICAL GENETICS 13/47 :-,2012
  • Demonstration of safety and enhanced seroprotection against hepatitis B with investigational HBsAg-1018 ISS vaccine compared to a licensed hepatitis B vaccine
    VACCINE 30/16 :2689-2696,2012
  • Genome-wide association study confirming association of HLA-DP with protection against chronic hepatitis B and viral clearance in Japanese and Korean
    PLOS ONE 7/6 :e39175-e39175,2012
  • Risk Assessment of Development of Hepatic Decompensation in Histologically Proven Hepatitis B Viral Cirrhosis Using Liver Stiffness Measurement
    DIGESTION 85/3 :219-227,2012
  • Prediction of Esophageal Variceal Bleeding in B-Viral Liver Cirrhosis Using the P2/MS Noninvasive Index Based on Complete Blood Counts.
    DIGESTION 86/3 :264-272,2012
  • Combined measurement of preoperative α-fetoprotein and des-γ-carboxy prothrombin predicts recurrence after curative resection in patients with hepatitis-B-related hepatocellular carcinoma
    INTERNATIONAL JOURNAL OF CANCER 131/10 :2332-2341,2012
  • How Many Valid Measurements Are Necessary to Assess Liver Fibrosis Using FibroScan? in Patients with Chronic Viral Hepatitis? An Analysis of Subjects with at Least 10 Valid Measurements
    YONSEI MEDICAL JOURNAL 53/2 :337-345,2012
  • Antiviral efficacy of lamivudine versus entecavir in patients with hepatitis B virus-related advanced hepatocellular carcinoma.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY 27/9 :1528-1534,2012
  • Liver Stiffness Measurement Using Acoustic Radiation Force Impulse (ARFI) Elastography and Effect of Necroinflammation
    DIGESTIVE DISEASES AND SCIENCES 57/6 :1682-1691,2012
  • A Comparative Analysis of Hepatocellular Carcinoma after Hepatic Resection in Young versus Elderly Patients
    JOURNAL OF GASTROINTESTINAL SURGERY 16/9 :1736-1743,2012
  • Prospective Validation of ELF Test in Comparison with Fibroscan and FibroTest to Predict Liver Fibrosis in Asian Subjects with Chronic Hepatitis B
    PLOS ONE 7/7 :-,2012
  • Lamivudine plus adefovir vs. entecavir in HBeAg-positive hepatitis B with sequential treatment failure of lamivudine and adefovir
    LIVER INTERNATIONAL 32/7 :1179-1185,2012
  • The accuracy of noninvasive methods in predicting the development of hepatocellular carcinoma and hepatic decompensation in patients with chronic hepatitis B
    JOURNAL OF CLINICAL GASTROENTEROLOGY 46/6 :518-525,2012
  • Prediction of liver-related events using fibroscan in chronic hepatitis B patients showing advanced liver fibrosis
    PLOS ONE 7/5 :e36676-e36676,2012
  • Combination of preS Deletions and A1762T/G1764A Mutations in HBV Subgenotype C2 Increases the Risk of Developing HCC
    INTERVIROLOGY 55/4 :296-302,2012
  • Optimal Time for Restoring the Reliability of Liver Stiffness Measurement in Patients With Chronic Hepatitis B Experiencing Acute Exacerbation
    JOURNAL OF CLINICAL GASTROENTEROLOGY 46/ :602-607,2012
  • Applicability of BCLC stage for prognostic stratification in comparison with other staging systems: Single centre experience from long-term clinical outcomes of 1717 treatment-na?ve patients with hepatocellular carcinoma
    LIVER INTERNATIONAL 32/7 :1120-1127,2012
  • "Normal" liver stiffness values differ between men and women: A prospective study for healthy living liver and kidney donors in a native Korean population
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY 27/4 :781-788,2012
  • Spontaneous Bacterial Peritonitis in Patients with Hepatitis B Virus-Related Liver Cirrhosis: Community-Acquired versus Nosocomial
    YONSEI MEDICAL JOURNAL 53/2 :328-336,2012
  • Acute Variceal Hemorrhage in Patients with Liver Cirrhosis: Weekend versus Weekday Admissions
    YONSEI MEDICAL JOURNAL 53/2 :318-327,2012
  • Clinical characteristics and prognosis of hepatocellular carcinoma with different sets of serum AFP and PIVKA-II levels
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY 24/7 :849-856,2012
  • Prospective validation of Fibrotest in comparison with liver stiffness for predicting liver fibrosis in Asian subjects with chronic hepatitis B
    PLOS ONE 7/4 :1-8,2012
  • Sorafenib versus cytotoxic chemotherapy for patients with advanced hepatocellular carcinoma: a retrospective, single-institution study
    INVESTIGATIONAL NEW DRUGS 30/3 :1150-1157,2012
  • Radiological response predicts survival following transarterial chemoembolisation in patients with unresectable hepatocellular carcinoma
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS 35/11 :1343-1350,2012
  • Hepatocellular carcinoma in Budd-Chiari syndrome: A single center experience with long-term follow-up in South Korea
    WORLD JOURNAL OF GASTROENTEROLOGY 18/16 :1946-1952,2012
  • PREDICTIVE VALUE OF HBSAG QUANTIFICATION FOR DETERMINING THE CLINICAL COURSE OF GENOTYPE C HBEAG-NEGATIVE CARRIERS
    LIVER INTERNATIONAL 32/5 :796-802,2012
  • Prediction of microvascular invasion of hepatocellular carcinoma: Usefulness of peritumoral hypointensity seen on gadoxetate disodium-enhanced hepatobiliary phase images
    JOURNAL OF MAGNETIC RESONANCE IMAGING 35/ :629-634,2012
  • Normal liver elasticity values using acoustic radiation force impulse imaging: A prospective study in healthy living liver and kidney donors
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY 27/1 :130-136,2012
  • Early on-treatment predictions of clinical outcomes using alpha-fetoprotein and des-gamma-carboxy prothrombin responses in patients with advanced hepatocellular carcinoma
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY 27/2 :313-322,2012
  • Clinical characteristics of acute hepatitis A complicated by acute kidney injury
    SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES 44/ :144-148,2012
  • Prediction of Significant Fibrosis in Chronic Hepatitis C Patients with Normal ALT
    HEPATO-GASTROENTEROLOGY 58/109 :1321-1327,2011
  • Controversies in Surveillance and Early Diagnosis of Hepatocellular Carcinoma
    ONCOLOGY 81/suppl :56-60,2011
  • Comparison of multiplex restriction fragment mass polymorphism and sequencing analyses for detecting entecavir resistance in chronic hepatitis B
    ANTIVIRAL THERAPY 16/1 :77-87,2011
  • Clinical Characteristics and Treatment Outcomes of Hepatocellular Carcinoma with Inferior Vena Cava/Heart Invasion
    ANTICANCER RESEARCH 31/12 :4641-4646,2011
  • Prevention of Hepatocellular Carcinoma in Patients with Chronic Hepatitis B Virus Infection
    ONCOLOGY 81/ :41-49,2011
  • Prognostic value of 18F-FDG PET for hepatocellular carcinoma patients treated with sorafenib
    LIVER INTERNATIONAL 31/8 :1144-1149,2011
  • Hepatitis B Virus Serology to Predict Antiviral Response in Chronic Hepatitis B
    DIGESTION 84/ :29-34,2011
  • HBV genotypes: relevance to natural history, pathogenesis and treatment of chronic hepatitis B
    ANTIVIRAL THERAPY 16/8 :1169-1186,2011
  • Clinical Features and Prognosis of Hepatocellular Carcinoma With Respect to Pre-S Deletion and Basal Core Promoter Mutations of Hepatitis B Virus Genotype C2
    JOURNAL OF MEDICAL VIROLOGY 83/12 :2088-2095,2011
  • Prognostic value of the 7th edition of the AJCC staging system as a clinical staging system in patients with hepatocellular carcinoma
    EUROPEAN JOURNAL OF CANCER 47/17 :2568-2575,2011
  • Quantification of HBsAg: Basic virology for clinical practice
    WORLD JOURNAL OF GASTROENTEROLOGY 17/3 :283-289,2011
  • Risk estimation for hepatocellular carcinoma in chronic hepatitis B (REACH-B): development and validation of a predictive score
    LANCET ONCOLOGY 12/6 :568-574,2011
  • Gastroduodenal Complications After Concurrent Chemoradiation Therapy in Patients with Hepatocellular Carcinoma: Endoscopic Findings and Risk Factors.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS 81/5 :1343-1351,2011
  • Adjuvant Hepatic Arterial Infusional Chemotherapy with 5-Fluorouracil and Cisplatin after Curative Resection of Hepatocellular Carcinoma
    ONCOLOGY 81/3-4 :184-191,2011
  • Early α-fetoprotein response as a predictor for clinical outcome after localized concurrent chemoradiotherapy for advanced hepatocellular carcinoma
    LIVER INTERNATIONAL 31/3 :369-376,2011
  • "Normal" range of alanine aminotransferase levels for Asian population
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY 26/2 :219-220,2011
  • 18F-fluorodeoxyglucose uptake on positron emission tomography as a prognostic predictor in locally advanced hepatocellular carcinoma
    CANCER 117/0 :4779-4787,2011
  • Clinicopathological Characteristics in Combined Hepatocellular-Cholangiocarcinoma: A Single Center Study in Korea
    YONSEI MEDICAL JOURNAL 52/5 :753-760,2011
  • Non-invasive assessment of liver fibrosis: The gap between ideal and real
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY 26/6 :937-939,2011
  • Partial virological response to entecavir in treatment-naive patients with chronic hepatitis B
    ANTIVIRAL THERAPY 16/4 :469-477,2011
  • Risk Assessment of Esophageal Variceal Bleeding in B-Viral Liver Cirrhosis by a Liver Stiffness Measurement-Based Model
    AMERICAN JOURNAL OF GASTROENTEROLOGY 106/9 :1654-1662,2011
  • Risk Assessment of Hepatitis B Virus-Related Hepatocellular Carcinoma Development Using Liver Stiffness Measurement (FibroScan)
    HEPATOLOGY 53/3 :885-894,2011
  • 간세포암 환자에서 간동맥화학색전술 후 발생한 간십이지장 누공
    대한소화기학회지(The Korean Journal of Gastroenterology) 58/3 :149-152,2011
  • 간세포암 파열 환자에서 단계적 간 절제술 후 광범위 조기 재발이 발생한 1예
    대한간암연구학회지 11/2 :155-159 ,2011
  • 비보상성 간경화를 가진 간세포암 환자에서 간 절제와 비장절제를 동시에 시행한 1예
    대한간암연구학회지 11/2 :160-164,2011
  • Quantitative Hepatitis B Surface Antigen and Hepatitis B e Antigen Titers in Prediction of Treatment Response to Entecavir
    HEPATOLOGY 53/5 :1486-1493,2011
  • Predictive factors for long-term survival in patients with clinically significant portal hypertension following resection of hepatocellular carcinoma
    LIVER INTERNATIONAL 31/4 :485-493,2011
  • Long-term clinical outcomes of hepatic arterial infusion chemotherapy with cisplatin with or without 5-fluorouracil in locally advanced hepatocellular carcinoma
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY 137/4 :659-667,2011
  • Transient elastography in chronic hepatitis B: An Asian perspective
    WORLD JOURNAL OF GASTROENTEROLOGY 16/41 :5173-5180,2010
  • Toll-like Receptor Polymorphisms are not Associated with Liver Cirrhosis in Hepatitis B Virus Infected Korean Patients
    Hepato-Gastroenterology 57/104 :1351-1355,2010
  • Autologous Bone Marrow Infusion Activates the Progenitor Cell Compartment in Patients With Advanced Liver Cirrhosis
    Cell Transplantation 19/10 :1237-1246,2010
  • Non-invasive assessment of changes in liver fibrosis via liver stiffness measurement in patients with chronic hepatitis B: impact of antiviral treatment on fibrosis regression
    Hepatology International 4/ :673-680,2010
  • Correlation between quantitative serum HBsAg and HBV DNA test in Korean patients who showed high level of HBsAg
    Journal Of Clinical Pathology 63/11 :1027-1031,2010
  • The Impact of Steatosis on Liver Stiffness Measurement in Patients with Chronic Hepatitis B
    Hepato-Gastroenterology 57/ :832-838,2010
  • Molecular and Clinical Characteristics of Hepatitis B Virus in Korea
    Journal Of Medical Virology 82/7 :1126-1134,2010
  • Chronic hepatitis B: whom to treat and for how long? Propositions, challenges, and future directions
    Hepatology International 4/1 :386-395,2010
  • 만성 B형간염 치료에서 바이러스 반응률에 대한 예측인자
    The Korean Journal of Hepatology(대한간학회지) 16/1 :1-4,2010
  • Non-invasive assessment of liver fibrosis: Time to move from cross-sectional studies to longitudinal ones
    Journal of Gastroenterology and Hepatology 25/9 :1472-1473,2010
  • Factors that affect the diagnostic accuracy of liver fibrosis measurement by Fibroscan in patients with chronic hepatitis B
    Alimentary Pharmacology & Therapeutics 32/3 :498-505,2010
  • 동일한 항암제 조합으로 치료하여 전신항암요법에서는 진행성질환 상태를, 국소적 간동맥 항암제주입요법에서는 부분관해를 보인 간세포암종 1예
    대한간암연구회지 10/ :44-48,2010
  • Validation of FIB-4 and comparison with other simple noninvasive indices for predicting liver fibrosis and cirrhosis in hepatitis B virus-infected patients
    LIVER INTERNATIONAL 30/4 :546-553,2010
  • External Validation of P2/MS and Comparison with Other Simple Non-invasive Indices for Predicting Liver Fibrosis in HBV-Infected Patients
    Digestive Diseases And Sciences 55/9 :2636-2643,2010
  • A novel liver stiffness measurement-based prediction model for cirrhosis in hepatitis B patients
    LIVER INTERNATIONAL 30/7 :1073-1081,2010
  • 간문맥혈전증을 동반한 특발성 문맥고혈압 환자에서 Protein C, Protein S 결핍 1예
    The Korean Journal of Hepatology(대한간학회지) 16/2 :176-181,2010
  • Efficacy of Adefovir Add-On Lamivudine Rescue Therapy Compared With Switching to Entecavir Monotherapy in Patients With Lamivudine-Resistant Chronic Hepatitis B
    Journal Of Medical Virology 82/11 :1835-1842,2010
  • A Case of Embryonal Sarcoma of the Liver Mimicking a Hydatid Cyst in an Adult
    GUT AND LIVER 4/2 :245-249,2010
  • Association Between Polymorphism of Tumor Necrosis Factor-alpha Promoter and Response to Lamivudine Treatment in Patients with Chronic Hepatitis B
    Digestive Diseases And Sciences 55/7 :2043-2048,2010
  • How Can We Enhance the Performance of Liver Stiffness Measurement Using FibroScan in Diagnosing Liver Cirrhosis in Patients With Chronic Hepatitis B?
    Journal Of Clinical Gastroenterology 44/1 :66-71,2010
  • Clinical Efficacy of a 24-months Course of Lamivudine Therapy in Patients with HBeAg Negative Chronic Hepatitis B: A Long-term Prospective Study
    JOURNAL OF KOREAN MEDICAL SCIENCE 25/6 :882-887,2010
  • Prospective validation of P2/MS noninvasive index using complete blood counts for detecting oesophageal varices in B-viral cirrhosis
    LIVER INTERNATIONAL 30/6 :860-866,2010
  • Can preoperative diffusion-weighted MRI predict postoperative hepatic insufficiency after curative resection of HBV-related hepatocellular carcinoma? A pilot study
    Magnetic Resonance Imaging 28/6 :802-811,2010
  • A Liver Stiffness Measurement-Based, Noninvasive Prediction Model for High-Risk Esophageal Varices in B-Viral Liver Cirrhosis
    American Journal of Gastroenterology 105/6 :1382-1390,2010
  • Long-term adefovir dipivoxil monotherapy for up to 5 years in lamivudine-resistant chronic hepatitis B
    Antiviral Therapy 15/2 :235-241,2010
  • What are 'true normal' liver stiffness values using FibroScan ? : a prospective study in healthy living liver and kidney donors in South Korea
    LIVER INTERNATIONAL 30/2 :268-274,2010
  • Lamivudine Maintenance Beyond One Year After HBeAg Seroconversion Is a Major Factor for Sustained Virologic Response in HBeAg-Positive Chronic Hepatitis B
    Hepatology 51/ :415-421,2010
  • Ascitic fluid infection in patients with hepatitis B virus-related liver cirrhosis: Culture-negative neutrocytic ascites versus spontaneous bacterial peritonitis
    Journal of Gastroenterology and Hepatology 25/1 :122-128,2010
  • Liver Stiffness Measurement in Combination With Noninvasive Markers for the Improved Diagnosis of B-viral Liver Cirrhosis
    Journal Of Clinical Gastroenterology 43/3 :267-271,2009
  • Liver stiffness measurement using FibroScan((R)) is influenced by serum total bilirubin in acute hepatitis
    Liver International 29/6 :810-815,2009
  • Clinical Features and Prognosis of Spontaneous Bacterial Peritonitis in Korean Patients with Liver Cirrhosis: A Multicenter Retrospective Study
    GUT AND LIVER 3/3 :197-204,2009
  • 유전자 1형 만성 C형간염 환자에서 페그인터페론과 리바비린의 24주와 48주 치료 효과 비교
    The Korean Journal Of Hepatology(대한간학회지) 15/4 :496-503,2009
  • Preoperative Radiologic and Postoperative Pathologic Risk Factors for Early Intra-Hepatic Recurrence in Hepatocellular Carcinoma Patients Who Underwent Curative Resection
    Yonsei Medical Journal 50/6 :789-795,2009
  • Efficacy and Safety of Transarterial Chemoembolization in Recurrent Hepatocellular Carcinoma After Curative Surgical Resection
    American Journal Of Clinical Oncology-Cancer Clinical Trials 32/6 :564-569,2009
  • Recombinant interferon-Beta-1 a plus ribavirin for the treatment of chronic HCV infection: A prospective, randomized, comparative pilot study
    GUT AND LIVER 3/1 :20-25,2009
  • Ascites and spontaneous bacterial peritonitis: An Asian perspective
    Journal Of Gastroenterology And Hepatology 24/9 :1494-1503,2009
  • celecoxib induces hepatic stellate cell apoptosis through inhibition of Akt activation and suppresses hepatic fibrosis in rats.
    Gut 58/ :1517-1527,2009
  • Clarification Required for the Definition of Hepatitis B Virus Subgenotypes C1 and C2
    Intervirology 52/6 :321-322,2009
  • Rescue monotherapy in lamivudine-resistant hepatitis B e antigen-positive chronic hepatitis B: Adefovir versus entecavir
    Antiviral Therapy 14/5 :705-712,2009
  • 간부전 환자에서 MARS? (Molecular Adsorbents Recirculating System)을 이용한 체외 간 지지요법의 유용성과 안정성에 대한 예비 결과
    Korean Journal Of Gastroenterology 54/1 :28-35,2009
  • 20세 미만의 젊은 연령에서 발병한 간세포암종 1예
    대한간암연구회지 9/ :71-75,2009
  • Usefulness of FibroScan for Detection of Early Compensated Liver Cirrhosis in Chronic Hepatitis B
    Digestive Diseases And Sciences 54/8 :1758-1763,2009
  • Variability in liver stiffness values from different intercostal spaces
    Liver International 29/5 :760-766,2009
  • Hepatitis B e Antigen-Negative Mutations in the Precore and Core Promoter Regions in Korean Patients
    Journal Of Medical Virology 81/4 :594-601,2009
  • Specific Mutations in the Enhancer II/Core Promoter/Precore Regions of Hepatitis B Virus Subgenotype C2 in Korean Patients With Hepatocellular Carcinoma
    Journal Of Medical Virology 81/6 :1002-1008,2009
  • Clinical course of virologic breakthrough after emergence of YMDD mutations in HBeAg-positive chronic hepatitis B
    Intervirology 51/4 :293-298,2008
  • Prevalence and genotype distribution of hepatitis C virus among apparently healthy individuals in Mongolia: a population-based nationwide study
    Liver International 28/ :1389-1395,2008
  • Prediction of postoperative hepatic insufficiency by liver stiffness measurement (FibroScan??) before curative resection of hepatocellular carcinoma: A pilot study
    Hepatology International 2/4 :471-477,2008
  • Clinical Features and Treatment Outcomes of Upper Gastrointestinal Bleeding in Patients with Cirrhosis
    Journal Of Korean Medical Science 23/4 :635-643,2008
  • Hepatocellular carcinoma presenting with bone metastasis: clinical characteristics and prognostic factors
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY 134/ :1377-1384,2008
  • Prediction of microvascular invasion before curative resection of hepatocellular carcinoma
    Journal Of Surgical Oncology 97/3 :246-252,2008
  • Fatal spontaneous bacterial peritonitis by Leclercia adecarboxylata in a patient with hepatocellular carcinoma
    International Journal Of Clinical Practice 62/ :1296-1298,2008
  • Natural history of hepatitis B virus-related cirrhotic patients hospitalized to control ascites
    Journal Of Gastroenterology And Hepatology 23/11 :1722-1727,2008
  • 음주로 인한 사회경제적 비용
    가정의학회지 29/3 :201-212,2008
  • 양측 담관을 침범한 간문부 간세포암을 토모테라피를 이용한 함암화학-방사선 동시요법으로 치료한 1예
    대한간암연구회지 (Journal of The Korean Liver Cancer Study Group) 8/ :102-105,2008
  • Predictive value of liver cell dysplasia for development of hepatocellular carcinoma in patients with chronic hepatitis B
    Journal Of Clinical Gastroenterology 42/6 :738-743,2008
  • Combination therapy of thymosin alpha-1 and lamivudine for HBeAg positive chronic hepatitis B: A prospective randomized, comparative pilot study
    Journal Of Gastroenterology And Hepatology 23/ :729-735,2008
  • 다발성 폐전이를 동반한 진행성 간세포암종 환자에서 전신항암화학요법의 치료성적
    대한간학회지(Korean Journal of Hepatolo) 14/3 :360-370,2008
  • High prevalence of significant histology in asymptomatic chronic hepatitis B patients with genotype C and high serum HBV DNA levels
    JOURNAL OF VIRAL HEPATITIS 15/ :615-621,2008
  • 동시 항암화학-방사선 요법 후 근치적 간절제술을 시행한 간세포암 1예
    대한간암연구회지 (Journal of The Korean Liver Cancer Study Group) 8/ :98-101,2008
  • MDM2 and p53 polymorphisms are associated with the development of hepatocellular carcinoma in patients with chronic hepatitis B virus infection
    Carcinogenesis 29/ :1192-1196,2008
  • Pilot clinical trial of localized concurrent chemoradiation therapy for locally advanced hepatocellular carcinoma with portal vein thrombosis
    Cancer 113/5 :995-1003,2008
  • Persistent hepatitis B viral replication affects recurrence of hepatocellular carcinoma after curative resection
    Liver International 28/ :393-401,2008
  • Anti-hepatitis A virus seroprevalence among patients with chronic viral liver disease in Korea
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY 19/11 :923-926,2007
  • 만성 B형 간염환자에서 간탄력도 측정에 의한 간섬유화의 비침습적 평가
    대한내과학회지 72/5 :459-469,2007
  • What is the role of diagnostic laparoscopy in a gastroenterology unit?
    JOURNAL OF GASTROENTEROLOGY 42/ :881-886,2007
  • Changes in serum and ascitic monocyte chemotactic protein-1 (MCP-1) and IL-10 levels in cirrhotic patients with spontaneous bacterial peritonitis
    JOURNAL OF INTERFERON AND CYTOKINE RESEARCH 27/ :227-230,2007
  • Long-term outcome of chronic hepatitis B based on histological grade and stage
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY 22/3 :383-388,2007
  • Radiation-induced hepatic toxicity after radiotherapy combined with chemotherapy for hepatocellular carcinoma
    HEPATOLOGY RESEARCH 37/ :906-913,2007
  • PIVKA-II is a useful tumor marker for recurrent hepatocellular carcinoma after surgical resection
    ONCOLOGY 72/S1 :52-57,2007
  • Role of(18)F-Fluorodeoxyglucose positron Emission Tomography in detecting Extrahepatic Metastasisin pretreatment staging of hin pretreatment staging of hepatocellular carcinoma
    ONCOLOGY 72/S1 :104-110,2007
  • 이차성 비기능항진증에서 부분적 비장동맥색전술의 장기 치료 효과
    대한내과학회지 72/5 :470-479,2007
  • 하대정맥 침습 또는 심방 종양혈전증을 보이는 진행 간세포암종의 임상 특징과 치료에 따른 예후
    The Korean Journal of Hepatology(대한간학회지) 13/3 :387-395,2007
  • 동시 항암 화학-방사선 요법 후 근치적 간절제술을 시행한 하대정맥 침습이 있는 진행성 간세포암종 1예
    대한간암연구회지 7/ :77-81,2007
  • Evaluation of the prognostic value of Okuda, Cancer of the Liver Italian Program, and Japan Integrated Staging systems for hepatocellular carcinoma patients undergoing radiotherapy
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS 67/4 :1037-1042,2007
  • MRP2 haplotypes confer differential susceptibility to toxic liver injury
    PHARMACOGENETICS AND GENOMICS 17/6 :403-415,2007
  • Repetitive short-course hepatic arterial infusion chemotherapy with high-dose 5-fluorouracil and cisplatin in patients with advanced hepatocellular carcinoma
    CANCER 110/1 :129-137,2007
  • Noninvasive models to predict liver cirrhosis in patients with chronic hepatitis B
    LIVER INTERNATIONAL 27/7 :969-976,2007
  • Clinical outcome of renal transplantation in patients with positive pre-transplant hepatitis B surface antigen
    JOURNAL OF MEDICAL VIROLOGY 79/11 :1655-1663,2007
  • 라미부딘으로 유도된 b형 간염 표면항원 소실 예에서의 간내 바이러스 양상
    대한내과학회지(korean Journal of medcine) 71/ :s998-s1002,2006
  • 간세포암 치료에서 수술 전 간동맥 화학색전술의 효과
    대한내과학회지 70/1 :17-25,2006
  • HBeAg 음성 만성 B형간염바이러스 감염의 자연경과: 코호트 연구
    The Korean Journal of Hepatology(대한간학회지) 12/2 :163-172,2006
  • Efficacy and long-term follow up of combination therapy with interferon alpha and ribavirin for chronic hepatitis C in Korea
    YONSEI MEDICAL JOURNAL 47/ :793-798,2006
  • A case of hypervascular hyperplastic nodule in a patient with alcoholic liver cirrhosis
    YONSEI MEDICAL JOURNAL 47/6 :881-886,2006
  • 급성 A형 전격성 간염(Fulminant hepatitis)과 동반된 급성 신부전증 1예
    The Korean Journal of Nephrology 25/1 :103-108,2006
  • Long-term clinical outcome of phase IIb clinical trial of percutaneous injection with holmium-166/chitosan complex (milican) for the treatment of small hepatocellular carcinoma
    CLINICAL CANCER RESEARCH 12/6 :543-548,2006
  • Association of genetic variations in CCR5 and its ligand, RANTES with clearance of hepatitis B virus in Korea
    JOURNAL OF MEDICAL VIROLOGY 78/12 :1564-1571,2006
  • The clinical impact of early detection of the YMDD mutant on the outcomes of long-term lamivudine therapy in patients with chronic hepatitis B
    ANTIVIRAL THERAPY 11/ :447-455,2006
  • 간문맥종양혈전증을 동반한 간세포암종에서 반복적인 간동맥 내 항암약물주입요법의 효과
    The Korean Journal of Hepatology(대한간학회지) 11/2005 :268-274,2005
  • Usefulness of urine strip test in the rapid diagnosis of spontaneous bacterial peritonitis
    LIVER INTERNATIONAL 25/ :1197-1201,2005
  • 간세포암종 환자에서 폐전이 시 폐절제술의 임상적 결과
    The Korean Journal of Hepatology(대한간학회지) 11/4 :350-358,2005
  • 간세포암 환자에서 간동맥 화학색전술 후 발생한 급성 간부전의 위험인자
    대한내과학회지(korean Journal of medcine) 69/6 :622-630,2005
  • Tuberculous mesenteric lymphadenitis involving the gastric wall: Case report
    GASTROINTESTINAL ENDOSCOPY 62/5 :799-802,2005
  • Comparison of rifaximin and lactulose for the treatment of hepatic encephalopathy: A prospective randomized study
    YONSEI MEDICAL JOURNAL 46/3 :399-407,2005
  • 한국인에서 Chemokine 수용체 (CCR5) promoter 유전자 다형성과 B형간염 바이러스 감염 후 임상 경과와의 상관성
    The Korean Journal of Hepatology(대한간학회지) 11/2 :116-124,2005
  • 간세포암의 진단과 재발판정에서 PIVKA-II의 유용성
    대한내과학회지(korean Journal of medcine) 69/1 :39-45,2005
  • Long-term clinical outcome of large volume paracentesis with intravenous albumin in patients with spontaneous bacterial peritonitis: A randomized prospective study
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY 20/ :1215-1222,2005
  • Evaluation of methods for monitoring drug resistance in chronic hepatitis B patients during lamivudine therapy based on mass spectrometry and reverse hybridization
    ANTIVIRAL THERAPY 10/3 :441-449,2005
  • How to predict HCC development in patients with chronic B viral liver disease?
    INTERVIROLOGY 48/1 :23-28,2005
  • Long-term clinical and histological outcomes in patients with spontaneous hepatitis B surface antigen seroclearance
    JOURNAL OF HEPATOLOGY 42/2 :188-194,2005
  • 진행성 간세포암종에서 동시 항암화학방사선 치료 후 발생한 급성 간기능 악화 2예
    대한간암연구회지 5/ :52-56,2005
  • 동시 항암 화학-방사선 요법 후 근치적 간절제술을 시행한 제4기 간세포암종 1예
    대한간암연구회지 5/ :22-26,2005
  • 한국인에서 전격성 간부전의 임상적 특징 및 예후 인자
    The Korean Journal of Hepatology(대한간학회지) 10/4 :298-307,2004
  • 말디도프 질량 분석을 이용한 한국인의 B형간염 바이러스 유전자형 및 임상적 의의에 대한 재평가
    The Korean Journal of Hepatology(대한간학회지) 10/4 :260-270,2004
  • Treatment outcome of transcatheter arterial chemoinfusion according to anticancer agents and prognostic factors in patients with advanced hepatocellular carcinoma (TNM stage IVa)
    YONSEI MEDICAL JOURNAL 45/5 :847-858,2004
  • Hepatitis B virus infection after renal transplantation in the presence of antibody to hepatitis B surface antigen immunity
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY 19/ :847-853,2004
  • 한국인에서 전격성 간부전의 임상적 특징 및 예후 인자
    The Korean Journal of Hepatology(대한간학회지) 10/4 :298-307,2004
  • 자발성 세균성 복막염 환자에서 치료 경과에 따른 복수 Nitric oxide(NO)의 변화
    The Korean Journal of Hepatology(대한간학회지) 10/3 :207-215,2004
  • 간암 조기 진단을 위한 개인별 간암발생 예측모형의 유용성
    대한내과학회지(korean Journal of medcine) 67/1 :7-14,2004
  • 간결핵으로 발생한 고칼슘혈증 1예
    대한내분비학회지(Joornal of the Korean Society of Endocrinol) 19/1 :64-68,2004
  • Sequence variation upstream of precore translation initiation codon reduces hepatitis B virus e antigen production
    GASTROENTEROLOGY 125/0 :1370-1378,2003
  • 차세대 B형 간염 항바이러스제의 전망
    Taehan Kan Hakhoe Chi 9/2 :20-26,2003
  • Evolution of hepatitis B virus sequence from a liver transplant recipient with rapid breakthrough despite hepatitis B immune globulin prophylaxis and lamivudine therapy
    JOURNAL OF MEDICAL VIROLOGY 71/0 :367-375,2003
  • Paired peritoneoscopic biopy and histological changes before and after spontaneous loss of hepatitis B surface antigen
    The Korean Journal of Hepatology(대한간학회지) 9/3 :9-9,2003
  • Genome Replication, Virion Secretion, and e Antigen Expression of Naturally Occurring Hepatitis B Virus Core Promoter Mutants
    JOURNAL OF VIROLOGY 77/12 :6601-6612,2003
  • A case of hepatocellular carcinoma arising from dysplastic nodule
    JOURNAL OF KOREAN MEDICAL SCIENCE 3/0 :80-86,2003
  • Concurrent Chemo-Radiation Therapy with Implanted Chemoport for Advanced Hepatocellular Carcinoma with Portal Vein Thrombosis
    대한간학회지 8/1 :71-79,2002
  • Total necrosis of hepatocellular carcinoma due to spontaneous occlusion of feeding atery
    YONSEI MEDICAL JOURNAL 43/0 :123-127,2002
  • Establishment of Individual Prediction Model According to Risk Factors for Development of Hepatocellular Carcinoma in Korea
    대한간학회지 7/4 :449-458,2001
  • Histopathologic correlation between chronic B viral hepatitis and nephropathy
    대한간학회지 7/4 :413-422,2001
  • Additional Lamivudine Therapy after HBeAg seroconversion Would Prolong the Durability of Response in HBV Endemic Area
    대한간학회지 7/4 :423-431,2001
  • Risk Factors for Hepatocellular carcinoma in Korea
    대한한방내과학회지 60/0 :124-130,2001
  • An ischemic skin lesion after chemoembolization of the right internal mammary artery in a patient with hepatocellular carcinoma
    YONSEI MEDICAL JOURNAL 42/1 :137-142,2001
  • Colonic metastasis from gastric carcinoma presenting as multiple polyps. Korean
    대한소화기내시경학회지(Korean J Gastrointest Endosc) 20/0 :299-302,2000
  • Association between Hepatitis B Virus Infection and HLA-DR Type in Korea
    HEPATOLOGY 31/0 :1371-1373,2000
  • Treatment outcome and prognostic factors in patients with advanced hepatocellular carcinoma (TNM Stage IVa) according to anticancer drugs of transhepatic arterial chemoinfusion
    대한간학회지 6/4 :456-467,2000
  • Establishment of a screening test system for early diagnosis of hepatocellular carcinoma in high-risk patients and the evaluation of its effectiveness
    대한암학회지 32/0 :1084-1092,2000
  • A case of spontaneously regressed hepatocellular carcinoma found after lobectomy of liver
    대한소화기학회지 36/0 :562-566,2000
  • Long-term outcome of chronic hepatitis B according to the new histological classification
    대한간학회지 6/0 :287-300,2000
  • A case of Peutz-Jeghers syndrome treated with segmental resection of ileum and intraoperative endoscopic polypectomy
    대한소화기내시경학회지(Korean J Gastrointest Endosc) 20/0 :207-212,2000

안상훈

진료철학
환자와 보호자의 입장에서 질병 뿐만 아니라 마음까지 치료할 수 있는 의사가 되고자 합니다. ‘창의와 열정으로 간질환 분야를 선도하고자’했던 저의 미션대로 최고의 실력으로 최상의 진료를 하겠습니다. 환자를 존중하고 환자에게 존경받을 수 있는 삶을 위해서 노력하겠습니다.

콘텐츠 처음으로 이동

네크워크 링크안내/사이트 정보